McKenna M J, Freaney R, Casey O M, Towers R P, Muldowney F P
J Clin Pathol. 1983 Mar;36(3):245-52. doi: 10.1136/jcp.36.3.245.
Data from a retrospective study in 41 patients is used to suggest an index of bone disease. This is designed as a means of collating available results, clarifying the significance of each in diagnosing either osteomalacia or osteoporosis, and reducing the significance of a single abnormal finding--for example, a raised alkaline phosphatase activity or low serum 25 hydroxy vitamin D, when the overall index score is low. Index scores above 35% would be diagnostic of osteomalacia; scores below 15% if associated with collapsed vertebrae suggest osteoporosis. Scores between 15% and 35% would indicate the need for a bone biopsy to discriminate between osteoporosis and osteomalacia.
一项针对41名患者的回顾性研究数据被用于提出一种骨病指数。其设计目的是整理现有结果,阐明各项结果在诊断骨软化症或骨质疏松症中的意义,并降低单一异常发现(例如,当总体指数评分较低时,碱性磷酸酶活性升高或血清25-羟维生素D水平降低)的重要性。指数评分高于35%可诊断为骨软化症;若与椎体压缩相关且评分低于15%则提示骨质疏松症。评分在15%至35%之间表明需要进行骨活检以区分骨质疏松症和骨软化症。